HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ikuko Tsukamoto Selected Research

psicose (D-psicose)

11/2015Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus.
1/2015Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.
1/2014Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose.
9/2012Rare sugar D-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats.
2/2011Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
8/2009Growth inhibition of head and neck carcinomas by D-allose.
11/2005Neuroprotective effect of D-psicose on 6-hydroxydopamine-induced apoptosis in rat pheochromocytoma (PC12) cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ikuko Tsukamoto Research Topics

Disease

6Body Weight (Weight, Body)
01/2019 - 02/2011
5Neoplasms (Cancer)
11/2018 - 10/2005
4Fibrosis (Cirrhosis)
04/2019 - 09/2012
4Insulin Resistance
11/2015 - 02/2011
4Hyperglycemia
11/2015 - 09/2012
4Type 2 Diabetes Mellitus (MODY)
11/2015 - 02/2011
2Stroke (Strokes)
09/2021 - 11/2016
2Infarction (Infarctions)
01/2019 - 04/2013
2Brain Ischemia (Cerebral Ischemia)
11/2016 - 04/2013
2Hypoxia (Hypoxemia)
03/2016 - 05/2015
2Obesity
11/2015 - 01/2015
1Spinal Cord Injuries (Spinal Cord Injury)
09/2021
1Systemic Scleroderma (Systemic Sclerosis)
04/2019
1Myocardial Infarction
01/2019
1Brain Edema (Cerebral Edema)
11/2016
1Cerebral Hemorrhage
11/2016
1Hypertension (High Blood Pressure)
11/2015
1Weight Gain
11/2015
1Glucose Intolerance
11/2015
1Dyslipidemias (Dyslipidemia)
11/2015
1Atherosclerosis
11/2015
1Inflammation (Inflammations)
05/2015
1Body Weight Changes
01/2015
1Hyperlipidemias (Hyperlipidemia)
01/2014
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
04/2013
1Ischemic Stroke
04/2013
1Carcinoma (Carcinomatosis)
08/2009
1Squamous Cell Carcinoma of Head and Neck
08/2009
1Burkitt Lymphoma (Burkitt's Lymphoma)
05/2009
1Leukemia
05/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2005
1Pheochromocytoma
11/2005
1Parkinson Disease (Parkinson's Disease)
11/2005

Drug/Important Bio-Agent (IBA)

7psicose (D-psicose)IBA
11/2015 - 11/2005
7SugarsIBA
11/2015 - 11/2005
5Coenzyme A (CoA)IBA
09/2021 - 04/2013
4Insulin (Novolin)FDA Link
11/2015 - 02/2011
4Glucose (Dextrose)FDA LinkGeneric
01/2014 - 08/2009
3Neuroprotective AgentsIBA
09/2021 - 11/2005
3Proteins (Proteins, Gene)FDA Link
11/2018 - 05/2009
3Blood Glucose (Blood Sugar)IBA
01/2015 - 02/2011
3alloseIBA
08/2009 - 10/2005
2Adenosine (Adenocard)FDA LinkGeneric
09/2021 - 11/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
04/2019 - 08/2017
2ThioredoxinsIBA
11/2018 - 05/2009
2FructoseIBA
01/2014 - 08/2009
1Angiotensin IIIBA
04/2019
1Connective Tissue Growth FactorIBA
04/2019
1NucleosidesIBA
11/2016
1Transcription Factors (Transcription Factor)IBA
03/2016
1Metformin (Glucophage)FDA LinkGeneric
11/2015
1ThiazolidinedionesIBA
11/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2015
12Cl-C.OXT-AIBA
04/2013
1Nucleic AcidsIBA
04/2013
1Hematoxylin (Haematoxylon)IBA
09/2012
1Eosine Yellowish-(YS) (Eosin)IBA
09/2012
1Amino AcidsFDA Link
11/2007
1Glutamic Acid (Glutamate)FDA Link
11/2007
1AcidsIBA
11/2007
1RadiopharmaceuticalsIBA
11/2007
1Oxidopamine (6 Hydroxydopamine)IBA
11/2005
1Glutathione (Reduced Glutathione)IBA
11/2005
1Biological ProductsIBA
10/2005

Therapy/Procedure

1Ligation
01/2019
1Therapeutics
11/2018
1Glycemic Control
11/2015
1Caloric Restriction
11/2015
1Intravenous Administration
01/2014
1Oral Administration
01/2014